Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Apr;5(1-2):59-65.
doi: 10.1016/s1353-8020(99)00015-2.

Drug-induced tardive syndromes

Affiliations

Drug-induced tardive syndromes

M Ortí-Pareja et al. Parkinsonism Relat Disord. 1999 Apr.

Abstract

We reviewed the database of five Movement Disorders Units to establish drugs responsible for tardive syndromes or TS (tardive dyskinesia, dystonia, akathisia, tremor, tics or tourettism, and myoclonus). The diagnostic criteria for TS included: (1) appearance of persistent dyskinesia, dystonia, akathisia, tremor, tics or tourettism, or myoclonus, related to prolonged drug exposure, (2) exclusion of other possible causes of these movement disorders. One-hundred patients fulfilled the diagnostic criteria for TS (26 males, 74 females, mean age 69.4+/-15.8 years). TS were related to 1, 2, 3, 4 and 5 drugs in 58, 27, 9, 5 and 1 patients, respectively. The most frequently offending drugs were antipsychotic drugs, substituted benzamides, thietylperazine and calcium-channel blockers. Seventy-two patients had buccolinguomasticatory syndrome, 30 had tremor, 22 akathisia and 16 dystonia (35 patients had a combination of at least two of these TS). Forty-two patients had coexistent parkinsonism. The TS disappeared following withdrawal of the offending drug in 40 cases. Old age and being female were more frequently associated with TS, with the exception of tardive dystonia. Substituted benzamides, calcium-channel blockers and thiethylperazine (a neuroleptic used for vertigo) were a frequent cause of TS in our series.

PubMed Disclaimer

Similar articles

  • The nosology of tardive syndromes.
    Frei K, Truong DD, Fahn S, Jankovic J, Hauser RA. Frei K, et al. J Neurol Sci. 2018 Jun 15;389:10-16. doi: 10.1016/j.jns.2018.02.008. Epub 2018 Feb 6. J Neurol Sci. 2018. PMID: 29433810
  • Drug-induced parkinsonism in a movement disorders unit: A four-year survey.
    Jiménez-Jiménez FJ, Ortí-Pareja M, Ayuso-Peralta L, Gasalla T, Cabrera-Valdivia F, Vaquero A, Tejeiro J, García-Albea E. Jiménez-Jiménez FJ, et al. Parkinsonism Relat Disord. 1996 Jul;2(3):145-9. doi: 10.1016/1353-8020(96)00013-2. Parkinsonism Relat Disord. 1996. PMID: 18591033
  • Drug-induced movement disorders.
    Jiménez-Jiménez FJ, García-Ruiz PJ, Molina JA. Jiménez-Jiménez FJ, et al. Drug Saf. 1997 Mar;16(3):180-204. doi: 10.2165/00002018-199716030-00004. Drug Saf. 1997. PMID: 9098656 Review.
  • Classification and treatment of tardive syndromes.
    Fernandez HH, Friedman JH. Fernandez HH, et al. Neurologist. 2003 Jan;9(1):16-27. doi: 10.1097/01.nrl.0000038585.58012.97. Neurologist. 2003. PMID: 12801428 Review.
  • [Orthostatic tremor induced by pharmaceuticals].
    Alonso-Navarro H, Ortí-Pareja M, Jiménez-Jiménez FJ, Zurdo-Hernández JM, de Toledo M, Puertas-Muñoz I. Alonso-Navarro H, et al. Rev Neurol. 2004 Nov 1-15;39(9):834-6. Rev Neurol. 2004. PMID: 15543499 Spanish.

Cited by

LinkOut - more resources